Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04113616 |
|---|---|
| Brief Title: | An Open-Label, Multicenter, Phase 1b/2 Study of the Safety and Efficacy of KRT-232 When Administered Alone and in Combination With Low-Dose Cytarabine (LDAC) or Decitabine in Patients With Acute Myeloid Leukemia (AML) |
| First Submitted : | October 1, 2019 |
| First Submitted that Met QC Criteria : | October 1, 2019 |
| First Posted : | October 3, 2019 |
| Last Update Submitted that Met QC Criteria : | August 3, 2022 |
| Last Update Posted : | August 4, 2022 |